Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Alkermes plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ALKS
Nasdaq
2836
www.alkermes.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alkermes plc
Are Investors Undervaluing Alkermes (ALKS) Right Now?
- Dec 8th, 2025 7:40 am
How Recent Deal Developments Are Reshaping The Avadel Pharmaceuticals Investment Story
- Dec 5th, 2025 5:20 pm
Announcement relating to despatch of Rule 15 proposal
- Dec 5th, 2025 2:01 pm
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
- Dec 3rd, 2025 2:47 pm
Should Alkermes (ALKS) Investors Reassess Prospects After Raised 2025 Guidance and Strong Q3 Results?
- Dec 2nd, 2025 4:13 am
Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting
- Dec 1st, 2025 2:05 pm
Why Is Alkermes (ALKS) Down 5.5% Since Last Earnings Report?
- Nov 27th, 2025 9:30 am
Avadel (AVDL) Drops 6.7% on Lack of Leads
- Nov 27th, 2025 7:22 am
Alkermes to Participate in Two Upcoming Investor Conferences
- Nov 25th, 2025 2:00 pm
How Analysts See the Alkermes Story Changing After Acquisition Moves and New Narcolepsy Data
- Nov 22nd, 2025 1:12 pm
AGIO Stock Hits 52-Week Low on Mixed Sickle Cell Disease Study Results
- Nov 20th, 2025 10:33 am
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal
- Nov 20th, 2025 7:14 am
Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck
- Nov 19th, 2025 2:20 pm
Sector Update: Health Care Stocks Mixed in Afternoon Trading
- Nov 19th, 2025 11:44 am
Alkermes prevails over Lundbeck in Avadel bidding war
- Nov 19th, 2025 11:44 am
Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri
- Nov 19th, 2025 8:59 am
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
- Nov 19th, 2025 4:00 am
Alkermes escalates bidding war; US biotech risks ‘falling behind’ China
- Nov 19th, 2025 3:33 am
TD Cowen Asserts Buy Rating as Alkermes plc (ALKS) Delivers Topline Results for Narcolepsy Treatment
- Nov 18th, 2025 10:25 pm
JAZZ Hits 52-Week High on Encouraging Gastric Cancer Study Data
- Nov 18th, 2025 10:16 am
Scroll